Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy

Kardiologia Polska

Volumn 61, Issue 10, 2004, Pages 350-355

  Iacob, Mihai ^a   Pinte, Florina ^a   Tintoiu, Ion ^a   Cotuna, Lucretia ^a   Coroescu, Mirela ^a   Popa, Alexandru ^a   Cristian, Gabriel ^a   Goleanu, Viorel ^a   Greere, Vasile ^a   Moscaliuc, Ion ^a   Neagoe, Gheorghe ^a   Crisan, Puiu ^a   Garjeu, Adriana ^a   Chiriac, Liviu ^a   Bolohan, Romi ^a   Murgu, Vasile ^a   Lobont, Beatrice ^a   Filip, Simona ^a   Roates, Jean ^a   Hila, Gabriel ^a   Postolea, Elena ^a   more..

^a Army's Center for Cardiovascular Diseases   (Romania)

Author keywords

Hypertrophic cardiomyopathy; Microcoil embolisation; Septal ablation

Indexed keywords

ALCOHOL; CREATINE KINASE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COIL EMBOLIZATION; DISEASE CLASSIFICATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GUIDE WIRE; HEART MUSCLE NECROSIS; HEART PACING; HEART SEPTAL HYPERTROPHY; HEART VENTRICLE PRESSURE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MEDICAL DOCUMENTATION; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PRESSURE GRADIENT; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 20844459126     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sigwart U.: Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 1995, 346, 211-214.
2. Knight C., Kurbaan A.S., Seggewiss H. et al.: Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997, 95, 2075-2081.
3. Seggewiss H., Gleichmann U., Faber L. et al.: Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J. Am. Coll. Cardiol. 1998, 31, 252-258.
4. Nagueh S.F., Ommen S.R., Lakkis N.M. et al.: Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J. Am. Coll. Cardiol. 2001, 38, 1701-1706.
5. Fananapazir L, McAreavey D.: Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms (Editorial Comment). J. Am. Coll. Cardiol. 1998, 31, 259-269.
6. Aroney C.N., Goh T.H., Hourigan L.A. et al.: Ventricular septal rupture following nonsurgical septal reduction for hypertrophic cardiomyopathy: treatment with percutaneous closure. Catheter. Cardivasc. Interv. 2004, 61, 411-414.
7. Kern M.J., Rajjoub H., Bach R.: Hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy. Cathet. Cardiovasc. Interv. 1999, 47, 221-228.
8. Oomman A., Ramachandran P., Subramanyan K. et al.: Transluminal Septal Myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results. J. Inv. Cardiol. 2001, 13, 526-530.
9. Gaspar J., Martinez-Rios M., Vonderwalde C. et al.: Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter. Cardiovasc. Interv. 1999, 47, 73-79.
10. Saucedo J.F., Guerra E.R., Joseph J. et al.: Clinical outcomes following treatment of hypertrophic obstructive cardiomyopathy using a PTFE-covered stent. Results of a prospective feasibility study. Am. J. Cardiol. 2003, 92, (suppl 1), 160-165.
11. Fifer M.A., Yoerger D.M., Picard M.H. et al.: Failure of covered stent implantation in the treatment of hypertrophic obstructive dardiomyopathy due to late collateral formation. Transcatheter Cardiovascular Therapeutics (www.tctmd.com): Cases & Images. Narrated cases: case presentation; august 4th, 2003.
12. Garza L., Saucedo J.F., Aude Y.W. et al.: Echocardiographic follow-up of a pilot study of PTFE-covered stent-induced septal artery ablation in hypertrophic obstructive cardiomyopathy: septal thickness reduction persistent at 3 months. Am. J. Cardiol. 2003, 92 (suppl 1), 160-165.
13. Uhlrich F., Waigand J., Gross CM. et al.: Transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy: embolization with particles instead of alcohol. Am. J. Cardiol. 1999, 84, (suppl 6A), 123P.
14. Iacob M., Pinte F., Tintoiu I. et al.: Microcoil embolization for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Abstract book; European Society of Cardiology Congress 2003, Vienna, P537.